These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 11280553

  • 1. Effect of ecabet sodium enema on mildly to moderately active ulcerative proctosigmoiditis: an open-label study.
    Kono T, Nomura M, Kasai S, Kohgo Y.
    Am J Gastroenterol; 2001 Mar; 96(3):793-7. PubMed ID: 11280553
    [Abstract] [Full Text] [Related]

  • 2. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
    Ardizzone S, Doldo P, Ranzi T, Sturniolo GC, Giglio LA, Annese V, D'Arienzo A, Gaia E, Gullini S, Riegler G, Valentini M, Massa P, Del Piano M, Rossini F, Guidetti CS, Pera A, Greinwald R, Bianchi Porro G.
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
    [Abstract] [Full Text] [Related]

  • 3. Ecabet sodium promotes the healing of trinitrobenzene-sulfonic-acid-induced ulceration by enhanced restitution of intestinal epithelial cells.
    Takagi T, Naito Y, Okuda T, Uchiyama K, Adachi S, Mizushima K, Handa O, Kokura S, Ichikawa H, Yoshikawa T.
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1259-65. PubMed ID: 20594253
    [Abstract] [Full Text] [Related]

  • 4. Cyclosporine enemas for treatment-resistant, mildly to moderately active, left-sided ulcerative colitis.
    Sandborn WJ, Tremaine WJ, Schroeder KW, Steiner BL, Batts KP, Lawson GM.
    Am J Gastroenterol; 1993 May; 88(5):640-5. PubMed ID: 8480724
    [Abstract] [Full Text] [Related]

  • 5. Treatment of refractory ulcerative proctosigmoiditis with butyrate enemas.
    Steinhart AH, Brzezinski A, Baker JP.
    Am J Gastroenterol; 1994 Feb; 89(2):179-83. PubMed ID: 8304299
    [Abstract] [Full Text] [Related]

  • 6. Budesonide foam versus budesonide enema in active ulcerative proctitis and proctosigmoiditis.
    Gross V, Bar-Meir S, Lavy A, Mickisch O, Tulassay Z, Pronai L, Kupcinskas L, Kiudelis G, Pokrotnieks J, Kovács A, Faszczyk M, Razbadauskas A, Margus B, Stolte M, Müller R, Greinwald R, International Budesonide Foam Study Group.
    Aliment Pharmacol Ther; 2006 Jan 15; 23(2):303-12. PubMed ID: 16393311
    [Abstract] [Full Text] [Related]

  • 7. Mesalamine foam enema versus mesalamine liquid enema in active left-sided ulcerative colitis.
    Cortot A, Maetz D, Degoutte E, Delette O, Meunier P, Tan G, Cazals JB, Dewit O, Hebuterne X, Beorchia S, Grunberg B, Leprince E, D'Haens G, Forestier S, Idier I, Lémann M.
    Am J Gastroenterol; 2008 Dec 15; 103(12):3106-14. PubMed ID: 19086960
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of ecabet sodium enema on steroid resistant or steroid dependent ulcerative colitis.
    Iizuka M, Itou H, Konno S, Shirasaka T, Horie Y, Shindo K, Watanabe S.
    Gut; 2006 Oct 15; 55(10):1523. PubMed ID: 16966708
    [No Abstract] [Full Text] [Related]

  • 9. An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.
    Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD.
    Am J Gastroenterol; 2001 Dec 15; 96(12):3323-8. PubMed ID: 11774944
    [Abstract] [Full Text] [Related]

  • 10. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P, Demling L.
    Hepatogastroenterology; 1980 Dec 15; 27(6):473-6. PubMed ID: 6110627
    [Abstract] [Full Text] [Related]

  • 11. Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis.
    Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A.
    Am J Gastroenterol; 2009 Feb 15; 104(2):437-43. PubMed ID: 19174792
    [Abstract] [Full Text] [Related]

  • 12. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial.
    Hanauer SB, Sandborn WJ, Kornbluth A, Katz S, Safdi M, Woogen S, Regalli G, Yeh C, Smith-Hall N, Ajayi F.
    Am J Gastroenterol; 2005 Nov 15; 100(11):2478-85. PubMed ID: 16279903
    [Abstract] [Full Text] [Related]

  • 13. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR, Kamm MA, Boddu P, Gubergrits N, Lyne A, Butler T, Lees K, Joseph RE, Sandborn WJ.
    Clin Gastroenterol Hepatol; 2007 Jan 15; 5(1):95-102. PubMed ID: 17234558
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of antibiotic combination therapy in patients with active ulcerative colitis, including refractory or steroid-dependent cases.
    Uehara T, Kato K, Ohkusa T, Sugitani M, Ishii Y, Nemoto N, Moriyama M.
    J Gastroenterol Hepatol; 2010 May 15; 25 Suppl 1():S62-6. PubMed ID: 20586868
    [Abstract] [Full Text] [Related]

  • 15. Drug evaluation: TA-2711E in the treatment of active distal ulcerative colitis.
    Monteleone G, Caprioli F.
    Curr Opin Investig Drugs; 2007 May 15; 8(5):423-8. PubMed ID: 17520872
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study.
    Biancone L, Gionchetti P, Blanco Gdel V, Orlando A, Annese V, Papi C, Sostegni R, D'Incà R, Petruzziello C, Casa A, Sica G, Calabrese E, Campieri M, Pallone F.
    Dig Liver Dis; 2007 Apr 15; 39(4):329-37. PubMed ID: 17347061
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of zinc-carnosine chelate compound, Polaprezinc, enemas in patients with ulcerative colitis.
    Itagaki M, Saruta M, Saijo H, Mitobe J, Arihiro S, Matsuoka M, Kato T, Ikegami M, Tajiri H.
    Scand J Gastroenterol; 2014 Feb 15; 49(2):164-72. PubMed ID: 24286534
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.